The Role of Alveolo-Arterial Oxygen Gradient and Pneumonia Severity Index in Predicting Mortality in Patients with Coronavirus Disease-19 Pneumonia

Abstract

Purpose of the study is to determine the success rates of alveolo-arterial oxygen gradient (AaDO2) and the pneumonia severity index (PSI) in predicting mortality for the patients diagnosed with COVID-19 pneumonia. This retrospective study included patients who were treated with the diagnosis of COVID-19 pneumonia in the ICUs. Demographic characteristics, arterial blood gas values, radiological images and laboratory data of the patients were used through the hospital database and patient files. Group I patients consist of alive and Group II patients consist of deceased persons. 150 of 263 patients included in this study are in Group I and 113 are in Group II. RT-PCR test was positive in 20.9% of the patients. The most common symptom was dyspnea with 76.5% and the most common additional disease was hypertension with 58.1%.65% of patients had radiological involvement in both lungs, and the most common finding was the ground-glass opacity at 70.7%.In predicting mortality, PSI value was 135 in group I and 174 in group II (p<0.001);AaDO2 value was 154.88 mmHg in group I, 177.13 mmHg in group II (p<0.001), and this rate was different between the groups.Sensitivity is found at 84.1% and specificity at 67.3% for PSI, whereas sensitivity is found at 49.6% and specificity at 82.7% for the AaDO2 variable. It is important to estimate the mortality risk earlier for the patients with COVID-19 pneumonia who are also followed up in intensive care units. PSI is beneficial in detecting mortality risk whereas AaDO2 is valuable in determining the surviving patients.

Keywords

• alveolo-arterial oxygen gradient
• COVID-19
• mortality
• pneumonia severity index

References

1. Referans1 Carlino MV, Valenti N, Cesaro F, Costanzo A, Cristiano G, et al. Predictors of intensive care unit admission in patients with coronavirus disease 2019 (COVID-19). Monaldi Arch Chest Dis. 2020;90(3):10.4081/monaldi.2020.1410.
2. Referans2 Mahase E. Covid-19: death rate is 0.66% and increases with age, study estimates. BMJ. 2020;369:m1327.
3. Referans3 Wendel Garcia PD, Fumeaux T, Guerci P, Heuberger DM, Montomoli J, Roche-Campo F, Schuepbach RA, Hilty MP; RISC-19-ICU Investigators. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort. EClinicalMedicine. 2020 Aug;25:100449.
4. Referans4 Özlü T, Bülbül Y, Alataş F, Arseven O, Coşkun AŞ, et al. Türk Toraks Derneği Erişkinlerde Toplumda Gelişen Pnömoni Tanı ve Tedavi Uzlaşı Raporu. Türk Toraks Derg. 2009;10(Suppl9):3-16.
5. Referans5 Loke YK, Kwok CS, Niruban A, Myint PK. Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis. Thorax. 2010;65(10):884-890.
6. Referans6 Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58(5):377-382.
7. Referans7 Fine MJ, Auble TE, Yealy DM, Hanusa B, Weissfeld LA, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250.
8. Referans8 Esteve F, Lopez-Delgado JC, Javierre C, Skaltsa K, Carrio ML, et al. Evaluation of the PaO2/FiO2 ratio after cardiac surgery as a predictor of outcome during hospital stay. BMC Anesthesiol. 2014;14:83.

9. Referans9 Hsu, JT, Chu CM, Chang ST, Cheng HW, Cheng NJ, Ho WC, et al. Prognostic role of alveolar-arterial oxygen pressure difference in acute pulmonary embolism. Circ J. 2006;70(12):1611–1616.
10. Referans10 Scientific Committee Study. Guide to COVID-19 (SARS-CoV-2 infection). TR. Ministry of Health, General Directorate of Public Health (2 April 2020) Ankara. 2020. https://covid19rehberi.com/wpcontent/uploads/2020/04/COVID19_Eriskin_Hasta_Tedavisi_02042020.pdf.
11. Referans11 Pan F, Yang L, Li Y, Liang B, Li L, et al. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study. Int J Med Sci. 2020;17(9):1281-1292.
12. Referans12 Xie J, Covassin N, Fan Z, Singh P, Gao W, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin Proc. 2020;95(6):1138-1147.
13. Referans13 Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, et al; STOP-COVID Investigators. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Intern Med. 2020;180(11):1–12.
14. Referans14 Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. MedRxiv. 2020 Apr 20:2020.04.15.20067157.
15. Referans15 Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, et al; COVID-19 Lombardy ICU Network. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345-1355.
16. Referans16 Singer AJ, Morley EJ, Meyers K, Fernandes R, Rowe AL, et al. Cohort of four thousand four hundred four persons under investigation for COVID-19 in a New York hospital and predictors of ICU care and ventilation. Ann Emerg Med. 2020;76(4):394-404.
17. Referasn17 Demirel B. Lactate levels and pneumonia severity index are good predictors of in-hospital mortality in pneumonia. Clin Respir J. 2018;12(3):991-995.
18. Referans18 Carlino MV, Guarino M, Izzo A, Carbone D, Arnone MI, et al. Arterial blood gas analysis utility in predicting lung injury in blunt chest trauma. Respir Physiol Neurobiol. 2020;274:103363.
19. Referans19 Awulachew E, Diriba K, Anja A, Getu E, Belayneh F. Computed Tomography (CT) ımaging features of patients with COVID-19: systematic review and meta-analysis. Radiol Res Pract. 2020;2020:1023506.
20. Referans20 Chen HJ, Qiu J, Wu B, Huang T, Gao Y, et al. Early chest CT features of patients with 2019 novel coronavirus (COVID-19) pneumonia: relationship to diagnosis and prognosis. Eur Radiol. 2020;30(11):6178-6185.
21. Referans21 Kuzan TY, Murzoğlu Altıntoprak K, Çiftçi HÖ, Ergül U, Ünal Özdemir NB, et al. A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission. Diagn Interv Radiol. 2021;27(3):336-43.
22. Refernas22 Lv M, Wang M, Yang N, Luo X, Li W, et al. Chest computed tomography for the diagnosis of patients with coronavirus disease 2019 (COVID-19): a rapid review and meta-analysis. Ann Transl Med. 2020;8(10):622.
23. Referans23 Fu B, Hu L, Lv F, Huang J, Li W, et al. Follow-up CT results of COVID-19 patients with initial negative chest CT. Infect Drug Resist. 2020;13:2681-2687.